Geriatrisches Zentrum

Zurück zum Hauptmenü
Zum Menü der Einrichtung

200
202
203
204
201

Adresse: Calwerstr. 14
72076 Tübingen

Telefonnummer: 07071 29-87517

Faxnummer: 07071 29-4628

Anfahrt Notfall

Publikationen von Mitarbeitern des GZ Tübingen 2016

  • Bacioglu M, Maia LF, Preische O, Schelle J, Apel A, Kaeser SA, Schweighauser M, Eninger T, Lambert M, Pilotto A, Shimshek DR, Neumann U, Kahle PJ, Staufenbiel M, Neumann M, Maetzler W, Kuhle J, Jucker M. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases. Neuron. 2016 Jul 20;91(2):494-496.
    Zum Abstract
  • Bacioglu M, Maia LF, Preische O, Schelle J, Apel A, Kaeser SA, Schweighauser M, Eninger T, Lambert M, Pilotto A, Shimshek DR, Neumann U, Kahle PJ, Staufenbiel M, Neumann M, Maetzler W, Kuhle J, Jucker M. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases. Neuron. 2016 Jul 6;91(1):56-66.
    Zum Abstract
  • Bernhard FP, Heinzel S, Binder G, Weber K, Apel A, Roeben B, Deuschle C, Maechtel M, Heger T, Nussbaum S, Gasser T, Maetzler W, Berg D. Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors. PLoS One. 2016 Mar 11;11(3):e0150552.
    Zum Abstract
  • Blauwendraat C, Wilke C, Jansen IE, Schulte C, Simón-Sánchez J, Metzger FG, Bender B, Gasser T, Maetzler W, Rizzu P, Heutink P, Synofzik M. Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants. Neurobiol Aging. 2016 Jan;37:208.e11-7.
    Zum Abstract
  • Brockmann K, Apel A, Schulte C, Schneiderhan-Marra N, Pont-Sunyer C, Vilas D, Ruiz-Martinez J, Langkamp M, Corvol JC, Cormier F, Knorpp T, Joos TO, Gasser T, Schüle B, Aasly JO, Foroud T, Marti-Masso JF, Brice A, Tolosa E, Marras C, Berg D, Maetzler W. Inflammatory profile in LRRK2-associated prodromal and clinical PD. J Neuroinflammation. 2016 May 24;13(1):122.
    Zum Abstract
  • Gardener SL, Sohrabi HR, Shen KK, Rainey-Smith SR, Weinborn M, Bates KA, Shah T, Foster JK, Lenzo N, Salvado O, Laske C, Laws SM, Taddei K, Verdile G, Martins RN. Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults. J Alzheimers Dis. 2016 Mar 31;52(2):661-72.
    Zum Abstract
  • Geib J, Rieger MA, Joos S, Eschweiler GW, Metzger FG. [Implementation of auricular acupuncture by the NADA protocol in geriatric patients suffering from major depression : A mixed methods feasibility study]. Z Gerontol Geriatr. 2016 May 4. [Epub ahead of print] German.
    Zum Abstract
  • Godinho C, Domingos J, Cunha G, Santos AT, Fernandes RM, Abreu D, Gonçalves N, Matthews H, Isaacs T, Duffen J, Al-Jawad A, Larsen F, Serrano A, Weber P, Thoms A, Sollinger S, Graessner H, Maetzler W, Ferreira JJ. A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease. J Neuroeng Rehabil. 2016 Mar 12;13:24.
    Zum Abstract
  • Godinho C, Domingos J, Cunha G, Santos AT, Fernandes RM, Abreu D, Gonçalves N, Matthews H, Isaacs T, Duffen J, Al-Jawad A, Larsen F, Serrano A, Weber P, Thoms A, Sollinger S, Graessner H, Maetzler W, Ferreira JJ. Erratum to: A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease. J Neuroeng Rehabil. 2016 Aug 1;13(1):71.
    Zum Abstract
  • Goldeck D, Maetzler W, Berg D, Oettinger L, Pawelec G. Altered dendritic cell subset distribution in patients with Parkinson's disease: Impact of CMV serostatus. J Neuroimmunol. 2016 Jan 15;290:60-5.
    Zum Abstract
  • Guerreiro R, Escott-Price V, Darwent L, Parkkinen L, Ansorge O, Hernandez DG, Nalls MA, Clark L, Honig L, Marder K, van der Flier W, Holstege H, Louwersheimer E, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns NJ, Halliday GM, Mann D, Pickering-Brown S, Powell J, Lunnon K, Lupton MK; International Parkinson's Disease Genomics Consortium., Dickson D, Hardy J, Singleton A, Bras J. Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases. Neurobiol Aging. 2016 Feb;38:214.e7-10.
    Zum Abstract
  • Heinzel S, Maechtel M, Hasmann SE, Hobert MA, Heger T, Berg D, Maetzler W. Motor dual-tasking deficits predict falls in Parkinson's disease: A prospective study. Parkinsonism Relat Disord. 2016 May;26:73-7.
    Zum Abstract
  • Heinzel S, Roeben B, Ben-Shlomo Y, Lerche S, Alves G, Barone P, Behnke S, Berendse HW, Bloem BR, Burn D, Dodel R, Grosset DG, Hu M, Kasten M, Krüger R, Moccia M, Mollenhauer B, Oertel W, Suenkel U, Walter U, Wirdefeldt K, Liepelt-Scarfone I, Maetzler W, Berg D. Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned. Front Aging Neurosci. 2016 Jun 22;8:147.
    Zum Abstract
  • Kern K, Naros G, Braun C, Weiss D, Gharabaghi A. Detecting a Cortical Fingerprint of Parkinson's Disease for Closed-Loop Neuromodulation. Front Neurosci. 2016 Mar 30;10:110.
    Zum Abstract
  • Klenk J, Srulijes K, Schatton C, Schwickert L, Maetzler W, Becker C, Synofzik M. Ambulatory Activity Components Deteriorate Differently across Neurodegenerative Diseases: A Cross-Sectional Sensor-Based Study. Neurodegener Dis. 2016;16(5-6):317-23.
    Zum Abstract
  • Klenk J, Schwickert L, Palmerini L, Mellone S, Bourke A, Ihlen EA, Kerse N, Hauer K, Pijnappels M, Synofzik M, Srulijes K, Maetzler W, Helbostad JL, Zijlstra W, Aminian K, Todd C, Chiari L, Becker C; FARSEEING Consortium.. The FARSEEING real-world fall repository: a large-scale collaborative database to collect and share sensor signals from real-world falls. Eur Rev Aging Phys Act. 2016 Oct 30;13:8.
    Zum Abstract
  • Lawton M, Kasten M, May MT, Mollenhauer B, Schaumburg M, Liepelt-Scarfone I, Maetzler W, Vollstedt EJ, Hu MT, Berg D, Ben-Shlomo Y. Validation of conversion between mini-mental state examination and montreal cognitive assessment. Mov Disord. 2016 Apr;31(4):593-6.
    Zum Abstract
  • Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, Saykin AJ, Masters CL, Ringman JM, Ryan NS, Förster S, Laske C, Schofield PR, Sperling RA, Salloway S, Correia S, Jack C Jr, Weiner M, Bateman RJ, Morris JC, Mayeux R, Brickman AM; Dominantly Inherited Alzheimer Network.. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016 Jun;79(6):929-39.
    Zum Abstract
  • Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Front Aging Neurosci. 2016 May 27;8:121.
    Zum Abstract
  • Lerche S, Brockmann K, Pilotto A, Wurster I, Sünkel U, Hobert MA, von Thaler AK, Schulte C, Stoops E, Vanderstichele H, Herbst V, Brix B, Eschweiler GW, Metzger FG, Maetzler W, Berg D. Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs. Alzheimers Res Ther. 2016 Oct 10;8(1):42.
    Zum Abstract
  • Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, McDade E, Ringman JM, Rossor M, Salloway S, Schofield PR, Holtzman DM, Morris JC, Bateman RJ; Dominantly Inherited Alzheimer Network.. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain. 2016 Oct;139(Pt 10):2766-2777.
    Zum Abstract
  • Maetzler W, Deleersnijder W, Hanssens V, Bernard A, Brockmann K, Marquetand J, Wurster I, Rattay TW, Roncoroni L, Schaeffer E, Lerche S, Apel A, Deuschle C, Berg D. GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia. PLoS One. 2016 Mar 3;11(3):e0149349.
    Zum Abstract
  • Maetzler W. A Viewpoint on Wearable Technology-Enabled Measurement of Wellbeing and Health-Related Quality of Life in Parkinson's Disease. J Parkinsons Dis. 2016 Mar 10;6(2):279-87.
    Zum Abstract
  • Maetzler W, Klucken J, Horne M. A clinical view on the development of technology-based tools in managing Parkinson's disease. Mov Disord. 2016 Sep;31(9):1263-71.
    Zum Abstract
  • Metzger FG, Hobert MA, Ehlis AC, Hasmann SE, Hahn T, Eschweiler GW, Berg D, Fallgatter AJ, Maetzler W; TREND Study team.. Dual Tasking for the Differentiation between Depression and Mild Cognitive Impairment. Front Aging Neurosci. 2016 Oct 13;8:235.
    Zum Abstract
  • Metzger FG, Schopp B, Haeussinger FB, Dehnen K, Synofzik M, Fallgatter AJ, Ehlis AC Brain activation in frontotemporal and Alzheimer's dementia: a functional near-infrared spectroscopy study. Brain activation in frontotemporal and Alzheimer's dementia: a functional near-infrared spectroscopy study. Alzheimers Res Ther. 2016 Dec 8;8(1):56.
    Zum Abstract
  • Roeben B, Maetzler W, Vanmechelen E, Schulte C, Heinzel S, Stellos K, Godau J, Huber H, Brockmann K, Wurster I, Gaenslen A, Grüner E, Niebler R, Eschweiler GW, Berg D; TREND study team.. Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus. J Alzheimers Dis. 2016 Mar 16;52(1):161-9.
    Zum Abstract
  • Ramsperger R, Meckler S, Heger T, van Uem J, Hucker S, Braatz U, Graessner H, Berg D, Manoli Y, Serrano JA, Ferreira JJ, Hobert MA, Maetzler W; SENSE-PARK study team.. Continuous leg dyskinesia assessment in Parkinson's disease -clinical validity and ecological effect. Parkinsonism Relat Disord. 2016 May;26:41-6.
    Zum Abstract
  • Sánchez-Ferro Á, Maetzler W. Advances in sensor and wearable technologies for Parkinson's disease. Mov Disord. 2016 Sep;31(9):1257.
    Zum Abstract
  • Sánchez-Ferro Á, Elshehabi M, Godinho C, Salkovic D, Hobert MA, Domingos J, van Uem JM, Ferreira JJ, Maetzler W. New methods for the assessment of Parkinson's disease (2005 to 2015): A systematic review. Mov Disord. 2016 Sep;31(9):1283-92.
    Zum Abstract
  • Santoro M, Maetzler W, Stathakos P, Martin HL, Hobert MA, Rattay TW, Gasser T, Forrester JV, Berg D, Tracey KJ, Riedel G, Teismann P. In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin. Neurobiol Dis. 2016 Jul;91:59-68.
    Zum Abstract
  • Schlenstedt C, Maetzler W. [Gait and balance disturbances of common age-associated neurologic diseases]. Dtsch Med Wochenschr. 2016 Sep;141(20):1441-1444. German.
    Zum Abstract
  • Scholten M, Klotz R, Plewnia C, Wächter T, Mielke C, Bloem BR, Braun C, Ziemann U, Govindan RB, Gharabaghi A, Krüger R, Weiss D. Neuromuscular correlates of subthalamic stimulation and upper limb freezing in Parkinson's disease. Clin Neurophysiol. 2016 Jan;127(1):610-20.
    Zum Abstract
  • Wagner CJ, Metzger FG, Sievers C, Marschall U, L'hoest H, Stollenwerk B, Stock S. Depression-related treatment and costs in Germany: Do they change with comorbidity? A claims data analysis. J Affect Disord. 2016 Mar 15;193:257-66.
    Zum Abstract
  • Wilke C, Gillardon F, Deuschle C, Hobert MA, Jansen IE, Metzger FG, Heutink P, Gasser T, Maetzler W, Blauwendraat C, Synofzik M. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia. Neurodegener Dis. 2016 Oct 20;17(2-3):83-88.
    Zum Abstract
  • Wilke C, Gillardon F, Deuschle C, Dubois E, Hobert MA, Müller vom Hagen J, Krüger S, Biskup S, Blauwendraat C, Hruscha M, Kaeser SA, Heutink P, Maetzler W, Synofzik M. Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease. Curr Alzheimer Res. 2016;13(6):654-62.
    Zum Abstract
  • Wilke C, Preische O, Deuschle C, Roeben B, Apel A, Barro C, Maia L, Maetzler W, Kuhle J, Synofzik M. Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum. J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1270-1272.
    Zum Abstract
  • van Lummel RC, Walgaard S, Hobert MA, Maetzler W, van Dieën JH, Galindo-Garre F, Terwee CB. Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease. PLoS One. 2016 Mar 21;11(3):e0151881.
    Zum Abstract
  • van Uem JM, Marinus J, Canning C, van Lummel R, Dodel R, Liepelt-Scarfone I, Berg D, Morris ME, Maetzler W. Health-Related Quality of Life in patients with Parkinson's disease--A systematic review based on the ICF model. Neurosci Biobehav Rev. 2016 Feb;61:26-34.
    Zum Abstract
  • van Uem JM, Maier KS, Hucker S, Scheck O, Hobert MA, Santos AT, Fagerbakke Ø, Larsen F, Ferreira JJ, Maetzler W. Twelve-week sensor assessment in Parkinson's disease: Impact on quality of life. Mov Disord. 2016 Sep;31(9):1337-8.
    Zum Abstract
  • van Uem JM, Walgaard S, Ainsworth E, Hasmann SE, Heger T, Nussbaum S, Hobert MA, Micó-Amigo EM, Van Lummel RC, Berg D, Maetzler W. Quantitative Timed-Up-and-Go Parameters in Relation to Cognitive Parameters and Health-Related Quality of Life in Mild-to-Moderate Parkinson's Disease. PLoS One. 2016 Apr 7;11(4):e0151997.
    Zum Abstract
  • Yilmaz R, Behnke S, Liepelt-Scarfone I, Roeben B, Pausch C, Runkel A, Heinzel S, Niebler R, Suenkel U, Eschweiler GW, Maetzler W, Berg D. Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults.Eur J Neurol. 2016 May;23(5):973-8.
    Zum Abstract
  • Yilmaz R, Gräber S, Roeben B, Suenkel U, von Thaler AK, Heinzel S, Metzger FG, Eschweiler GW, Maetzler W, Berg D, Liepelt-Scarfone I. Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson's Disease.Front Aging Neurosci. 2016 Nov 15;8:271.
    Zum Abstract
  • Yilmaz R, Pilotto A, Roeben B, Preische O, Suenkel U, Heinzel S, Metzger FG, Laske C, Maetzler W, Berg D.Structural Ultrasound of the Medial Temporal Lobe in Alzheimer's Disease. Ultraschall Med. 2016 Jun 7
    Zum Abstract

Zertifikate und Verbände

Focus: Top Nationales Krankenhaus 2024

Die deutschen Universitätsklinika

Kooperation für Transparenz und Qualität im Gesundheitswesen

Qualitätspartnerschaft mit der PKV

Blauer Sterne Betrieb

Erfolgsfaktor Familie

Die Altersvorsorge für den Öffentlichen Dienst